In this sense, the development of AKI in patients with COVID-19 has been associated with different variables, including smoking, increased levels of C-reactive protein (CRP), the extent of lung involvement, high leukocyte count, and the requirement for mechanical ventilation [14,15,16]. This evidence concerns the gene CRP and acute kidney injury.